BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 3969374)

  • 21. Should the Gleason grading system for prostate cancer be modified to account for high-grade tertiary components? A systematic review and meta-analysis.
    Harnden P; Shelley MD; Coles B; Staffurth J; Mason MD
    Lancet Oncol; 2007 May; 8(5):411-9. PubMed ID: 17466898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in prostate cancer grading: Including a new patient-centric grading system.
    Kryvenko ON; Epstein JI
    Prostate; 2016 Apr; 76(5):427-33. PubMed ID: 26709152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contemporary grading for prostate cancer: implications for patient care.
    Brimo F; Montironi R; Egevad L; Erbersdobler A; Lin DW; Nelson JB; Rubin MA; van der Kwast T; Amin M; Epstein JI
    Eur Urol; 2013 May; 63(5):892-901. PubMed ID: 23092544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
    Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
    J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Grading prostate cancer.
    Bostwick DG
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S38-56. PubMed ID: 7524306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Grading of prostatic cancer (I): An analysis of the prognostic significance of single characteristics.
    Schroeder FH; Blom JH; Hop WC; Mostofi FK
    Prostate; 1985; 6(1):81-100. PubMed ID: 3969374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Murphy GP; Busch C; Abrahamsson PA; Epstein JI; McNeal JE; Miller GJ; Mostofi FK; Nagle RB; Nordling S; Parkinson C
    Scand J Urol Nephrol Suppl; 1994; 162():7-42; discussion 115-27. PubMed ID: 7817162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
    Ladekarl M
    APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System.
    Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA;
    Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma.
    Epstein JI; Amin MB; Reuter VE; Humphrey PA
    Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproducibility and reliability of tumor grading in urological neoplasms.
    Engers R
    World J Urol; 2007 Dec; 25(6):595-605. PubMed ID: 17828603
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.